Update shared on 15 Dec 2025
Analysts have trimmed their price target on Iren slightly to EUR 2.90. This reflects a more cautious Hold stance as they factor in softer revenue growth assumptions, offset by a modestly improved profit margin outlook and a lower discount rate.
Analyst Commentary
Analyst sentiment around Iren has turned more balanced, with the shift to a Hold rating reflecting a view that much of the near term upside is now embedded in the shares at the updated EUR 2.90 price target.
While the overall stance is more cautious, research commentary highlights a mix of supportive factors and emerging risks tied to valuation, execution, and medium term growth visibility.
Bullish Takeaways
- Bullish analysts see the EUR 2.90 target as underpinned by resilient earnings visibility, supported by regulated and long term contracted activities that help protect cash flows.
- Improving margin assumptions, driven by ongoing efficiency measures and a more favorable cost environment, are viewed as a key driver of stable to slightly higher profitability over the forecast horizon.
- The current discount rate applied in valuation has been nudged lower, reflecting a perception of reduced risk in funding costs and capital structure. This supports a higher equity valuation than previously assumed.
- Growth in core businesses, particularly in energy and environmental services, is expected to remain steady enough to justify the current valuation, even if top line expansion is not especially rapid.
Bearish Takeaways
- Bearish analysts argue that softer revenue growth expectations limit upside, with a slower expansion profile constraining the potential for significant multiple re rating from current levels.
- There is concern that execution risk on planned investment projects could weigh on returns if timelines slip or regulatory conditions become less favorable, pressuring medium term growth targets.
- At the updated EUR 2.90 price target, the risk reward profile is seen as more balanced, with less margin of safety if macro conditions deteriorate or if cost savings fail to materialize as projected.
- Some caution that any negative shifts in interest rates or credit spreads could quickly offset the benefit of the lower discount rate used in current valuation models, putting the target price at risk.
Valuation Changes
- Fair Value: unchanged at approximately €2.93 per share, indicating no material shift in intrinsic value estimates.
- Discount Rate: fallen slightly from about 9.44 percent to 9.24 percent, reflecting a modestly lower perceived risk profile and funding cost.
- Revenue Growth: upgraded from an expected decline of roughly 1.51 percent to a smaller decline of about 0.85 percent, implying a less negative top line trajectory.
- Net Profit Margin: risen marginally from around 5.20 percent to 5.27 percent, pointing to a slightly stronger profitability outlook.
- Future P/E: edged down from about 14.58x to 14.26x, suggesting a modestly lower valuation multiple applied to forward earnings.
Have other thoughts on Iren?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.
